The Ascent Health and Wellness Solutions, Manipal Education and Medical Group, Medi Assist Healthcare Services and Prosus-backed online drugstore secured the funding at a $5.6bn valuation.
India-based, corporate-backed online pharmacy operator PharmEasy has closed a pre-initial public offering round sized at up to $344m, the Economic Times reported today, citing regulatory filings and people privy to the matter.
The round valued the company at $5.6bn and included about $204m in primary funding from Amansa Capital, ApaH Capital, Janus Henderson, OrbiMed, Steadview Capital, ADQ, Neuberger Berman and Sanne Group, all of which also acquired secondary shares from early investors.
The secondary transaction was sized between $130m and $140m and included some 20 senior team members purchasing a total of $5m in shares, sources told ET. PharmEasy founders paid about $40m to buy shares, while financial services group India Infoline also invested.
Founded in 2015, PharmEasy has built an online medicine marketplace that helps users buy prescription drugs, consumer health products and medical tests.
The company’s overall funding stood at over $650m as of a $350m primary and…
